Resources
Our goal is to transparently share knowledge, and in our work we review many scientific publications. Here’s a snapshot of top articles and videos, as well as some introductory material if you are new to the field. Enjoy!
Theranostics
Video Spotlights
Targeted Therapies
Check out this great video about Targeted Therapies in Cancer Treatment
177Lu-DOTA-octreotate
Application of radiolabeled peptides for targeted therapy; 177Lu-DOTA-octreotate emits gamma and beta particle radiation, the peptide molecules bind somatostatin receptors on tumor cells and can be applied for both tumor imaging and radionuclide therapy.
Targeted Alpha Therapies
How does Targeted Alpha therapy work? Check out this video to find out.
What is Targeted Therapy?
Insider info:
Lutetium
There’s much to see here. We are sharing “hot”, recent publications in the field of theranostics. So, take your time, look around, and learn. We hope you enjoy our library. More to come!
Lutetium Targeted Therapies
Current Status of 177 Lu-PSMA Targeted Therapies and Where Will We Be In the Near Future
ESMO Preliminary Results
ESMO 2019: Preliminary Results of a Phase I/II Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive mCRPC
Lutetium plus Idronoxil
Phase I/II Trial of Lutetium-177–PSMA-617 Plus Idronoxil in Metastatic Castration-Resistant Prostate Cancer
Radioligand Treatment
PSMA PET During Lu-177–PSMA Radioligand Therapy May Help Guide Treatment
Metastatic Prostate Cancer
Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer
Insider info:
Actinium
Advanced Prostate Cancer: 225-Ac-PSMA-618 Treatment
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Tandem Therapy of Prostate Cancer
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
Safety and Efficacy
Safety and Efficacy of Ac-225-PSMA-617 in mCRPC after Failure of Lu-177-PSMA
Insider info:
Iodine
Iodine Targeting
Iodine Symporter Targeting with 124I/131I Theranostics
Neuroblastoma Theranostics
¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
Neuroblastoma Imaging
MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
Insider info:
Zirconium
Zirconium as tool in Imaging
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
Zirconium in Oncology
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Zirconium Radiochemistry
89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry
Learning:
Want to know More about Theranostics?
Learning:
What are Monoclonal Antibodies?
Thank you for visiting our Library.
Knowledge is important in our business, we strive for the highest level of excellence in our business, service, and competencies. Feel free to reach out if you want more information.
Chat with the experts.
We’d love to understand your needs and help your patients.
